Comment: Immunotherapy combination for advanced NSCLC
Dr Marina Garassino - National Tumour Institute, Milan, Italy
28 Sep 2019
Comment: Front-line osimertinib significantly lengthens overall survival in EGFR...
Dr Marina Garassino - National Tumour Institute, Milan, Italy
28 Sep 2019
Important developments in radiation oncology
Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA
26 Jul 2019
New standard of care for lung cancer patients with EGFR mutations
Dr Gelenis Domingo - Memorial Healthcare System, Hollywood, FL, USA
26 Jul 2019
Lung cancer screening and the management of the pulmonary nodule
Dr Mark Block - Memorial Healthcare System, Hollywood, FL, USA
26 Jul 2019
Immunotherapy for lung cancer before surgery
Dr. Luis Raez - Memorial Cancer Institute, Florida, USA
19 Jul 2019
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in pa...
Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
10 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast ...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
10 Jul 2019
Gene expression in primary non-small cell lung cancer as a predictor of brain me...
Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel
10 Jul 2019
Integration of DNA and RNA investigations in clinical trials: A laboratory chall...
Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
The potential of PARP inhibitors in new cancer groups and in combination with ot...
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston,...
18 Jun 2019
